TEL AVIV, Israel and PARSIPPANY, N.J., May 17, 2021 /PRNewswire/ -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) (TASE: TEVA), today announced the launch ...
PARSIPPANY, N.J., and TEL AVIV, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the ...
Please provide your email address to receive an email when new articles are posted on . Teva Pharmaceuticals announced FDA approval of Austedo XR, a once-daily, extended-release formulation for adults ...
JERUSALEM, May 18 (Reuters) - Teva Pharmaceutical Industries' (TEVA.TA), opens new tab drug Austedo should reach sales of $2.5 billion by 2027, Chief Executive Richard Francis said on Thursday.
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved AUSTEDO™ (deutetrabenazine) tablets ...
Attuned to the burdens of people living with Huntington’s disease (HD) chorea and tardive dyskinesia (TD), Teva has been eager to cut the amount of pills patients need to take in half. Now, it's ...
With its generics unit under pressure, struggling Teva could use some help from its specialty department. And Monday’s approval of Huntington’s med Austedo should bring just that. The FDA approved the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results